Expanded Access Trial of Plant Expressed Recombinant Glucocerebrosidase (prGCD) in Patients With Gaucher Disease

Expanded access is currently available for this treatment.

Study NCT00962260 Information provided by Protalix

First Received: August 18, 2009 Last Updated: August 22, 2011 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	Expanded access is currently available for this treatment.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	No date given